Ablaze Pharmaceuticals, Yonghe Pharmaceutical in manufacturing agreement
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze from pharmaceutical research and preclinical activities to clinical studies
Yonghe Pharmaceutical | 29/12/2022 | By Sudeep Soparkar | 440
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy